189 related articles for article (PubMed ID: 18496560)
21. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.
Modlich U; Navarro S; Zychlinski D; Maetzig T; Knoess S; Brugman MH; Schambach A; Charrier S; Galy A; Thrasher AJ; Bueren J; Baum C
Mol Ther; 2009 Nov; 17(11):1919-28. PubMed ID: 19672245
[TBL] [Abstract][Full Text] [Related]
22. The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy.
Métais JY; Dunbar CE
Mol Ther; 2008 Mar; 16(3):439-49. PubMed ID: 18227842
[TBL] [Abstract][Full Text] [Related]
23. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
24. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
25. Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.
van der Loo JC; Swaney WP; Grassman E; Terwilliger A; Higashimoto T; Schambach A; Hacein-Bey-Abina S; Nordling DL; Cavazzana-Calvo M; Thrasher AJ; Williams DA; Reeves L; Malik P
Gene Ther; 2012 Aug; 19(8):872-6. PubMed ID: 22551777
[TBL] [Abstract][Full Text] [Related]
26. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
[TBL] [Abstract][Full Text] [Related]
27. CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors.
Gaussin A; Modlich U; Bauche C; Niederländer NJ; Schambach A; Duros C; Artus A; Baum C; Cohen-Haguenauer O; Mermod N
Gene Ther; 2012 Jan; 19(1):15-24. PubMed ID: 21562592
[TBL] [Abstract][Full Text] [Related]
28. Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes.
Unsinger J; Kröger A; Hauser H; Wirth D
Mol Ther; 2001 Nov; 4(5):484-9. PubMed ID: 11708885
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
30. Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.
Cornils K; Lange C; Schambach A; Brugman MH; Nowak R; Lioznov M; Baum C; Fehse B
Mol Ther; 2009 Jan; 17(1):131-43. PubMed ID: 19002163
[TBL] [Abstract][Full Text] [Related]
31. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.
Recchia A; Bonini C; Magnani Z; Urbinati F; Sartori D; Muraro S; Tagliafico E; Bondanza A; Stanghellini MT; Bernardi M; Pescarollo A; Ciceri F; Bordignon C; Mavilio F
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1457-62. PubMed ID: 16432223
[TBL] [Abstract][Full Text] [Related]
32. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C
Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA
Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Leukemia-Inducing Genes Using a Proto-Oncogene/Homeobox Gene Retroviral Human cDNA Library in a Mouse In Vivo Model.
Jang SH; Lee S; Chung HY
PLoS One; 2015; 10(11):e0143240. PubMed ID: 26606454
[TBL] [Abstract][Full Text] [Related]
35. Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients.
Cooper AR; Lill GR; Shaw K; Carbonaro-Sarracino DA; Davila A; Sokolic R; Candotti F; Pellegrini M; Kohn DB
Blood; 2017 May; 129(19):2624-2635. PubMed ID: 28351939
[TBL] [Abstract][Full Text] [Related]
36. Generation of an autocrine leukaemia using a retroviral expression vector carrying the interleukin-3 gene.
Hapel AJ; Vande Woude G; Campbell HD; Young IG; Robins T
Lymphokine Res; 1986; 5(4):249-54. PubMed ID: 3491251
[TBL] [Abstract][Full Text] [Related]
37. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
Chen W; Schweins E; Chen X; Finn OJ; Cheever MA
J Immunol; 1994 Oct; 153(8):3630-8. PubMed ID: 7930583
[TBL] [Abstract][Full Text] [Related]
38. Ex vivo expansion of retrovirally transduced primate CD34+ cells results in overrepresentation of clones with MDS1/EVI1 insertion sites in the myeloid lineage after transplantation.
Sellers S; Gomes TJ; Larochelle A; Lopez R; Adler R; Krouse A; Donahue RE; Childs RW; Dunbar CE
Mol Ther; 2010 Sep; 18(9):1633-9. PubMed ID: 20571542
[TBL] [Abstract][Full Text] [Related]
39. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.
Caudell D; Harper DP; Novak RL; Pierce RM; Slape C; Wolff L; Aplan PD
Blood; 2010 Feb; 115(6):1194-203. PubMed ID: 20007546
[TBL] [Abstract][Full Text] [Related]
40. Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.
Baum C; von Kalle C; Staal FJ; Li Z; Fehse B; Schmidt M; Weerkamp F; Karlsson S; Wagemaker G; Williams DA
Mol Ther; 2004 Jan; 9(1):5-13. PubMed ID: 14741772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]